EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials

Alexander D Sherry iD, Pavlos Msaouel iD, Ramez Kouzy iD, Joseph Abi Jaoude iD, Timothy A Lin iD, Cullen M Taniguchi iD, Clifton David Fuller iD, Bruce Minsky iD, Ethan B Ludmir iD

The Oncologist · 05.07.2024 · 29 (7) · 547-550

DOI: 10.1093/oncolo/oyae067 ↗

Kurz gefasst

Editorial in der Zeitschrift The Oncologist, online erschienen am 01.06.2024. Verfasst von Alexander D Sherry und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Hauptthemen laut MEDLINE: Clinical Trials, Phase III as Topic, Kaplan-Meier Estimate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Cancer Center Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Missing visual elements (MVE) in Kaplan-Meier (KM) curves can misrepresent data, preclude curve reconstruction, and hamper transparency. This study evaluated KM plots of phase III oncology trials. MVE were defined as an incomplete y-axis range or missing number at risk table in a KM curve. Surrogate endpoint KM curves were additionally evaluated for complete interpretability, defined by (1) reporting the number of censored patients and (2) correspondence of the disease assessment interval with the number at risk interval. Among 641 trials enrolling 518 235 patients, 116 trials (18%) had MVE in KM curves. Industry sponsorship, larger trials, and more recently published trials were correlated with lower odds of MVE. Only 3% of trials (15 of 574) published surrogate endpoint KM plots with complete interpretability. Improvements in the quality of KM curves of phase III oncology trials, particularly for surrogate endpoints, are needed for greater interpretability, reproducibility, and transparency in oncology research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase III as TopicKaplan-Meier EstimateHumansNeoplasmsMedical Oncology

Stichwörter der Autor:innen

Kaplan-Meierclinical researchdata visualizationphase IIIrandomized controlled trialstime-to-event outcomes

Autor:innen und Institutionen

  • Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Department of Radiation Oncology, Stanford University, Stanford, CA, United States.
  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

ORCID-Profile: Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce Minsky, Ethan B Ludmir

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Cancer Center Support
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Sherry, A. D., Msaouel, P., Kouzy, R., Abi Jaoude, J., Lin, T. A., Taniguchi, C. M., Fuller, C. D., Minsky, B., & Ludmir, E. B. (2024). Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The Oncologist, 29(7), 547-550. https://doi.org/10.1093/oncolo/oyae067

Vancouver

Sherry AD, Msaouel P, Kouzy R, Abi Jaoude J, Lin TA, Taniguchi CM, et al. Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The Oncologist. 2024;29(7):547-550. doi:10.1093/oncolo/oyae067

BibTeX
@article{Sherry2024,
  author = {Sherry, Alexander D and Msaouel, Pavlos and Kouzy, Ramez and Abi Jaoude, Joseph and Lin, Timothy A and Taniguchi, Cullen M and Fuller, Clifton David and Minsky, Bruce and Ludmir, Ethan B},
  title = {Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials},
  journal = {The Oncologist},
  year = {2024},
  volume = {29},
  number = {7},
  pages = {547--550},
  doi = {10.1093/oncolo/oyae067}
}
Kostenlos starten →